Euroscience Open Forum 2012
The Science-2-Business programme focuses on the process of transforming the outputs of publicly-funded research into successful business innovations. The Programme provides a multi-level set of activities that offer delegates the opportunity to follow the journey from Science to Business. It incorporated interactive workshops and a vibrant marketplace buzzing with the anticipation of potential collaborations.
Workshops provided practical help to nascent and established entrepreneurs from a scientific background to transform their ideas into viable business propositions. For example, “What do investors look for in business propositions?” and “Master-class on how to bring Research to Market” and “How can more SMEs engage in more Horizon 2020 projects?”.
Other workshops considered the environment for entrepreneurship e.g. Open Innovation, IPR, university licensing arrangements and entrepreneurship education.
The Invention Convention
The Invention Convention was a competitive opportunity for 15 people (professionals, innovators, entrepreneurs, Masters students, PhD candidates or Post Docs) to pitch their innovation in 3 minutes to a panel of distinguished judges comprising of experts from both the academic and business sectors.
The Market Place
The Marketplace was a nexus for the different elements of the business start-up ecosystem and is an integral part of the Science-2-Business programme. It featured participants, exhibitors and presenters from the public and private sectors and was located in the Forum Hall.
Visits to Incubation Centres
Delegates has the opportunity to visit a number of incubation centres located around Dublin on the Thursday and Friday of ESOF 2012.
The final element of the Science-2-Business programme was a keynote address by Dr Pearse Lyons. How did a scientist with $10,000 build a multi-billion dollar company? How did this private company, with no outside investors, rise to become no. 7 in the world of animal health? What does the future hold for Alltech as it heads for a target of $4 billion in sales?